Pruritus in palliative care: Getting up to scratch;Prurit en soins palliatifs: Gratter le fond de la question

Canadian Family Physician

Volumn 57, Issue 9, 2011, Pages

  Seccareccia, Dori ^a   Gebara, Nadine ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; COLESTYRAMINE; CYTOKINE; DIPHENHYDRAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; KAPPA OPIATE RECEPTOR; LIDOCAINE; MIRTAZAPINE; MU OPIATE RECEPTOR; NALOXONE; NALTREXONE; ONDANSETRON; PAROXETINE; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR;

ALLERGY; ARTICLE; BEDTIME DOSAGE; CANCER PATIENT; CHOLESTASIS; CHRONIC KIDNEY FAILURE; CLINICAL FEATURE; DRUG EFFICACY; DRUG ERUPTION; DRY SKIN; HEMODIALYSIS PATIENT; HUMAN; NERVE ENDING; PALLIATIVE THERAPY; PANCREAS CANCER; PARANEOPLASTIC SYNDROME; PROSTATE CANCER; PRURITUS; QUALITY OF LIFE; RISK FACTOR; SENSORY NERVE; SKIN CARE; SOLID TUMOR; TREATMENT RESPONSE; ULTRAVIOLET B RADIATION; UREMIA; VASOMOTOR REFLEX; XEROSIS;

ADRENAL CORTEX HORMONES; ANALGESICS, OPIOID; ANESTHETICS, LOCAL; ANTIPRURITICS; CHOLESTASIS; EMOLLIENTS; HISTAMINE H1 ANTAGONISTS; HODGKIN DISEASE; HUMANS; KIDNEY FAILURE, CHRONIC; NARCOTIC ANTAGONISTS; NEOPLASMS; PALLIATIVE CARE; POLYCYTHEMIA VERA; PRURITUS; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SKIN CARE; ULTRAVIOLET THERAPY;

EID: 80053034540     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Bernhard JD. Itch and pruritus: what are they, and how should itches be classified? Dermatol Ther 2005;18(4):288-91. (Pubitemid 41804994)
2. Walsh D, rédacteur. Palliative medicine. Expert consult: online and print. Philadelphie, PA: WB Saunders; 2008.
3. Yosipovitch G, Greaves MW, Schmelz M. Itch. Lancet 2003;361(9358):690-4. (Pubitemid 36253608)
4. Schmelz M, Handwerker HO. Neurophysiology. Dans: Zylicz Z, Twycross R, Jones EA, rédacteurs. Pruritus in advanced disease. Oxford, RU: Oxford University Press; 2004. p. 11-32.
5. Twycross R, Greaves MW, Handwerker H, Jones EA, Libretto SE, Szepietowski JC, et collab. Itch: scratching more than the surface. QJM 2003;96(1):7-26.
6. Lidstone V, Thorns A. Pruritus in cancer patients. Cancer Treat Rev 2001;27(5):305-12. (Pubitemid 33072297)
7. Szepietowski JC. Uraemic pruritus. Dans: Zylicz Z, Twycross R, Jones EA, rédacteurs. Pruritus in advanced disease. Oxford, RU: Oxford University Press; 2004. p. 69-83.
8. Krajnik M, Zylicz Z. Understanding pruritus in systemic disease. J Pain Symptom Manage 2001;21(2):151-68.
9. Krajnik M, Zylicz Z. Pruritus in advanced internal diseases. Pathogenesis and treatment. Neth J Med 2001;58(1):27-40. (Pubitemid 32013955)
10. Davis MP, Frandsen JL, Walsh D, Andresen S, Taylor S. Mirtazapine for pruritus. J Pain Symptom Manage 2003;25(3):288-91. (Pubitemid 36287087)
11. Zylicz Z, Krajnik M, Sorge AA, Costantini M. Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial. Pain Symptom Manage 2003;26(6):1105-12. (Pubitemid 37488018)
12. Jones EA, Bergasa NV. The pruritus of cholestasis and the opioid neurotramsitter system. Dans: Zylicz Z, Twycross R, Jones EA, rédacteurs. Pruritus in advanced disease. Oxford, RU: Oxford University Press; 2004. p. 56-68.
13. Terra SG, Tsunoda SM. Opioid antagonists in the treatment of pruritus from cholestatic liver disease. Ann Pharmacother 1998;32(11):1228-30. (Pubitemid 28543471)
14. O'Donohue JW, Pereira SP, Ashdown AC, Haigh CG, Wilkinson JR, Williams R. A controlled trial of ondansetron in the pruritus of cholestasis. Aliment Pharmacol Ther 2005;21(8):1041-5. (Pubitemid 40532979)
15. Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 2003;17(7):857-70. (Pubitemid 36459598)
16. Krajnik M, Zylicz Z. Pruritus accompanying solid tumours. Dans: Zylicz Z, Twycross R, Jones EA, rédacteurs. Pruritus in advanced disease. Oxford, RU: Oxford University Press; 2004. p. 97-106.
17. Krajnik M, Zylicz Z. Pruritus in haematological disorders. Dans: Zylicz Z, Twycross R, Jones EA, rédacteurs. Pruritus in advanced disease. Oxford, RU: Oxford University Press; 2004. p. 107-16.
18. Szepietowski J, Twycross R. Topical therapy. Dans: Zylicz Z, Twycross R, Jones EA, rédacteurs. Pruritus in advanced disease. Oxford, RU: Oxford University Press; 2004. p. 151-60.
19. Greaves MW. Itch in systemic disease: therapeutic options. Dermatol Ther 2005;18(4):323-7. (Pubitemid 41804996)
20. Twycross R, Zylicz Z. Systemic therapy: making rational choices. Dans: Zylicz Z, Twycross R, Jones EA, rédacteurs. Pruritus in advanced disease. Oxford, RU: Oxford University Press; 2004. p. 161-78.
21. Krajnik M. Opioid-induced pruritus. Dans: Zylicz Z, Twycross R, Jones EA,rédacteurs. Pruritus in advanced disease. Oxford, RU: Oxford University Press; 2004. p. 84-96.
22. Katcher J, Walsh D. Opioid-induced itching: morphine sulfate and hydromorphone hydrochloride. J Pain Symptom Manage 1999;17(1):70-2. (Pubitemid 29031738)